EPCO-22. IDENTIFYING NEOANTIGENS FOR A PERSONALIZED MUTATION-DERIVED GENOMIC VACCINE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

BACKGROUND: Glioblastomas (GBM) are known for having a lower mutational burden than many other tumor types. Nevertheless, somatic variants that occur in GBM mutational processes may give rise to neoantigens, which can be targeted in a personalized genomic vaccine to elicit a patient-specific anti-tu...

Full description

Saved in:
Bibliographic Details
Published in:Neuro Oncol
Main Authors: Kodysh, Julia, Rubinsteyn, Alex, Blazquez, Ana, Mandeli, John, Bhardwaj, Nina, Hormigo, Adilia
Format: Artigo
Language:Inglês
Published: Oxford University Press 2020
Subjects:
(Epi)Genetics and Computational Omics
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651423/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.301
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items